Stevanato Group S.p.A. has announced securing €200 million in financing through agreements with BNL BNP Paribas, Cassa Depositi e Prestiti, and Banco BPM. This funding is designated to support the company's ongoing capital expenditure projects in Cisterna di Latina, Italy, and Fishers, Indiana, U.S. The financing aligns with Stevanato Group's strategy to meet robust customer demand and achieve long-term growth objectives. Key partners, including BNL BNP Paribas and Cassa Depositi e Prestiti, have renewed their support, emphasizing their commitment to innovation and sustainability in the pharmaceutical and biotechnology sectors.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.